Liver disorders in Unani and modern medicine: current concepts, etiopathogenesis, diagnosis and future perspectives: a narrative review

Tayyaba Khatoon; Ataullah Fahad; Naved Ahmad

doi:10.18203/2320-6012.ijrms20264226

Authors

Tayyaba Khatoon Department of Ilmul Amraz, Faculty of Unani Medicine, Ajmal Khan Tibbiya College, Aligarh Muslim University, Aligarh, U. P., India
Ataullah Fahad Department of Ilmul Amraz, Faculty of Unani Medicine, Ajmal Khan Tibbiya College, Aligarh Muslim University, Aligarh, U. P., India
Naved Ahmad Department of Biochemistry, F. H. Medical College, Etmadpur, Agra, U. P., India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20264226

Keywords:

Liver disease, Hepatic disorders, Liver pathology, Hepatic pathophysiology, Unani medicine

Abstract

Liver diseases are a major cause of morbidity and mortality worldwide, encompassing a wide spectrum of conditions ranging from acute infections to chronic liver disorders and malignancies. Owing to the liver's central role in metabolism, detoxification and immune regulation, hepatic diseases are complex and require a comprehensive understanding. While modern medicine explains these disorders through pathological and biochemical mechanisms, Unani medicine interprets them on the basis of humoral imbalance and the principles of Ilmul Amraz. A narrative review was conducted by systematically searching electronic databases, including PubMed, Scopus, DOAJ, Wiley Online Library, Springer Link, Science Direct, MDPI, NCBI, Google Scholar and Index Copernicus. Relevant peer-reviewed articles, review papers and classical Unani texts were identified using predefined keywords related to liver diseases, hepatic disorders, Unani medicine and integrative medicine. The retrieved literature was critically analyzed and compared. The review demonstrates that both Unani and modern medicine provide valuable perspectives on liver diseases. Modern medicine offers detailed insights into disease mechanisms, diagnosis and evidence-based therapeutic strategies, whereas Unani medicine emphasizes on humoral equilibrium, temperament (Mizāj). Several complementary concepts were correlated, suggesting potential areas for integrative approaches in the prevention and later on management of liver disorders. An integrated understanding of liver diseases through both Unani and modern medical perspectives may enhance clinical decision-making and patient care. Future interdisciplinary research is warranted to validate traditional concepts and explore evidence-based integrative strategies for improving liver disease management.

References

Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008;134(6):1655-69.

Tiniakos DG, Lee JA, Burt AD. Innervation of the liver: morphology and function. Liver. 1996;16(3):151-60.

World Health Organization. Global hepatitis report, 2017. Geneva: WHO. 2017.

Kabiruddin M. Ifadae Kabir Mufassal. New Delhi: Central Council for Research in Unani Medicine (CCRUM). 2001.

Ghani MN. Khazinatul Adviya. Vol. 1. Lucknow: Matba Munshi Nawal Kishore. 1917.

Nasiruddin M. Ilaj bil Dawa (Pharmacotherapy in Unani). New Delhi: CCRUM. 2010.

Baghdadi IH. Kitab al-Mukhtarat fi al-Tibb. Vol. 1. New Delhi: CCRUM, Ministry of Health and Family Welfare, Government of India. 2005;48-9.

Kabeeruddin M. Tarjuma wa Sharah Kulliyat-e- Qanoon Part I and II New Delhi: Idara Kitab-ul-Shifa. 2015;54-5.

Rushd I. Kitab al Kulliyat. New Delhi: CCRUM, Ministry of Health and Family Welfare, Govt. of India. 1980;105-7.

Razi Z. Kitab al-Hawi. Vol.VII. New Delhi: CCRUM, Ministry of Health and Family Welfare, Government of India. 2000;119-25.

Baghdadi H. Kitab al-Mukhtarat fi al-Tibb. Vol. 3. New Delhi: CCRUM. 2004;292-304.

Khan MA. Akseere Azam. Idara Kitab-ul-Shifa; New Delhi. 2011;281-554.

Arzani HA. Tibbe Akbar. Idara Kitab-ul-Shifa, New Delhi. 2008;439-72.

Jurjani AH. Zakheera Khwarzam Shahi. Idara Kitabul-Shifa, New Delhi. 2010;328-426.

Tabri AHM. Moalajat-e-Buqratia. CCRUM, New Delhi. 1997;187-335.

Samarqandi N. Moalijat Shareh Asbab. Idara Kitab-ul-Shifa, New Delhi. Vol. 2, 3rd ed. 2014;542-87.

Rushd I. Kitab-ul-Kulliyat. Maktaba Daniyal, Lahore. 1987;105-11.

Akbar M. Mizan ul Tib. 2nd ed. Qaumi Council Barae Froogh Urdu Zaban, New Delhi. 2002;169-72.

Sina I. Al-Qanoon fi Tib. Idara Kitab-ul-Shifa, New Delhi. 2007;849-915.

Razi Z. Kitab-al-Hawi. Vol. 7. CCRUM, New Delhi. 2000;47-117.

Majoosi AH. Kamil-us-Sana'a. Vol. 1. New Delhi: Idara Kitab-us-Shifa. 2010.

Baghdadi I. Kitab-ul-Mukhtarat-Fil-Tibb. 1st ed., I. New Delhi: Central Council for Research in Unani Medicine. 2004.

Shah MH. The General Principles of Avicenna's Canon of Medicine. New Delhi: Idara Kitab-us-Shifa. 2007.

Sina I. Al-Qanoon fi al-Tibb. New Delhi: Idara Kitab-ul-Shifa. 2007;849-900.

Wazir H, Abid M, Essani B, Saeed H, Ahmad Khan M, Nasrullah F, et al. Diagnosis and Treatment of Liver Disease: Current Trends and Future Directions. Cureus. 2023;15(12):e49920.

Yao J, Guo J, Xie Y. Hepatitis B virus induced cirrhosis and hepatocarcinoma: pathogenesis and therapeutics. Explor Dig Dis. 2025;4:100565.

Osna NA, Donohue TM Jr, Kharbanda KK. Alcoholic Liver Disease: Pathogenesis and Current Management. Alcohol Res. 2017;38(2):147-61.

Paschos P, Paletas K. Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia. 2009;13(1):9-19.

Somnay K, Wadgaonkar P, Sridhar N, Roshni P, Rao N, Wadgaonkar R. Liver Fibrosis Leading to Cirrhosis: Basic Mechanisms and Clinical Perspectives. Biomedicines. 2024;12(10):2229.

Jain A, Mazer B, Deng Y, Ciarleglio M, Jain D, Taddei T, Zhang X. Hepatocellular Carcinoma: Does the Background Liver with or Without Cirrhosis Matter? Am J Clin Pathol. 2022;157(2):305-13.

Burra P, Cammà C, Invernizzi P, Marra F, Pompili M. Does the hepatologist still need to rely on aminotransferases in clinical practice? A reappraisal of the role of a classic biomarker in the diagnosis and clinical management of chronic liver diseases. Ann Hepatol. 2025;30(1):101900.

Vroon DH, Israili ZH. Alkaline phosphatase and gamma glutamyltransferase. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd ed. Boston: Butterworths. 1990;494-6.

Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci. 2001;38(4):263-355.

Guerra Ruiz AR, Crespo J, López Martínez RM, Iruzubieta P, Casals Mercadal G, Lalana Garcés M, et al. Measurement and clinical usefulness of bilirubin in liver disease. Adv Lab Med. 2021;2(3):352-72.

Harrison MF. The Misunderstood Coagulopathy of Liver Disease: A Review for the Acute Setting. West J Emerg Med. 2018;19(5):863-71.

Hanif H, Ali MJ, Susheela AT, Khan IW, Luna-Cuadros MA, Khan MM, Lau DT. Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma. World J Gastroenterol. 2022;28(2):216-29.

Mooli RGR, Mukhi D, Ramakrishnan SK. Oxidative Stress and Redox Signaling in the Pathophysiology of Liver Diseases. Compr Physiol. 2022;12(2):3167-92.

Vernuccio F, Cannella R, Bartolotta TV, Galia M, Tang A, Brancatelli G. Advances in liver US, CT, and MRI: moving toward the future. Eur Radiol Exp. 2021;5(1):52.